8-K: Onconetix Receives Nasdaq Delisting Notice Due to Low Share Price

Onconetix, Inc. has received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, triggering a compliance period to avoid delisting.

Summary

• Onconetix, Inc. received a notification from Nasdaq on January 23, 2025, stating that the company's stock price has fallen below the required minimum of $1.00 per share.
• This non-compliance is based on the closing bid price of the company's common stock between November 25, 2024, and January 10, 2025.
• The company has been granted a 180-day compliance period, until July 22, 2025, to regain compliance by having its stock price close at or above $1.00 for at least 10 consecutive business days.
• If the company fails to regain compliance within this period, they may be granted a second 180-day period if they meet other listing requirements and notify Nasdaq of their intent to cure the deficiency.
• Failure to regain compliance within the allotted time, including any extensions, could result in the delisting of Onconetix's common stock from the Nasdaq Capital Market.

Sentiment

Score: 3

Explanation: The document indicates a significant negative event (delisting notice) and uncertainty about the company's ability to regain compliance. The sentiment is therefore negative.

Positives

• The company has been granted a 180-day period to regain compliance.
• There is a possibility of a second 180-day extension if the company meets certain criteria.
• The company's listing remains fully effective during the compliance period.

Negatives

• The company's stock price has fallen below the minimum required for continued listing on the Nasdaq Capital Market.
• There is a risk of delisting if the company fails to regain compliance within the allotted time.

Risks

• There is no guarantee that the company will regain compliance with the minimum bid price requirement within the 180-day compliance period.
• There is no guarantee that the company will secure a second 180-day period to regain compliance.
• The company may not maintain compliance with other applicable Nasdaq listing requirements.
• Delisting from the Nasdaq Capital Market could negatively impact the company's stock price and investor confidence.

Future Outlook

The company will continue to monitor its stock price and seek to regain compliance with Nasdaq requirements within the allotted compliance periods. There is no assurance that the company will regain compliance.

Management Comments

• The company will continue to monitor the closing bid price of its Common Stock and seek to regain compliance with all applicable Nasdaq requirements within the allotted compliance periods.

Industry Context

Delisting notices are not uncommon for companies that experience a significant drop in their stock price. This situation highlights the importance of maintaining a healthy stock valuation to remain listed on major exchanges like Nasdaq.

Comparison to Industry Standards

• Many companies listed on the Nasdaq Capital Market face similar challenges in maintaining the minimum bid price.
• Companies like [hypothetical company A] and [hypothetical company B] have also received delisting notices in the past due to low share prices.
• The 180-day compliance period is a standard procedure for companies in this situation, as seen with [hypothetical company C] which was able to regain compliance within the allotted time.
• The ability to secure a second 180-day period is also a common practice, but it is not guaranteed and depends on meeting other listing requirements, similar to the case of [hypothetical company D].

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment.
• Employees may be concerned about the company's future.
• Customers and suppliers may have concerns about the company's stability.

Next Steps

• The company will monitor its stock price.
• The company will seek to regain compliance with Nasdaq requirements.
• The company may need to take actions to increase its stock price.

Key Dates

Keywords

delisting, Nasdaq, compliance, minimum bid price, stock price, ONCO, listing rule